Iliac Artery Disease
11
0
1
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
18.2%
2 terminated out of 11 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
NIRS and Exercise Intensity in Patients With FLIA
Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease
Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease
Endovascular Treatment of Peripheral Artery Disease (PAD)
AndraTec PMCF Study : Investigating the AndraTec Guidewires,PTA Balloons and Stents in Iliac Disease.
Iliac Angioplasties: Impact of the Fusion of Images on the Irradiation Rate
Endovascular Treatment of Peripheral Artery Disease
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
Endovascular Treatment of Aorto-iliac Occlusions
Korean Multicenter Registry of EPIC Stent for Iliac Artery Disease: (K-EPIC Registry)